Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saxon, R. S.
Right arrow Articles by Keller, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saxon, R. S.
Right arrow Articles by Keller, F. S.

Radiology, Vol 207, 683-693, Copyright © 1998 by Radiological Society of North America


ARTICLES

Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms

RS Saxon, PL Ross, J Mendel-Hartvig, RE Barton, K Benner, K Flora, BD Petersen, PC Lakin and FS Keller
Dotter Interventional Institute, Oregon Health Sciences University, Portland, USA.

PURPOSE: To analyze in detail the location and types of stenosis and occlusion that occur after transjugular intrahepatic portosystemic shunt (TIPS) creation and to determine the relative contribution of these various types of TIPS malfunction to recurrent symptoms of variceal bleeding or ascites. MATERIALS AND METHODS: In 116 of 217 patients who underwent TIPS creation between June 1990 and July 1995, follow-up portal venography was performed at 6-month intervals and for symptoms of recurrent variceal bleeding or ascites. RESULTS: Cumulative primary venographic patency by means of Kaplan-Meier survival analysis was 55% at 6 months and 5% at 2 years. Secondary patency was 92% at 2 years. Stenosis or occlusion occurred in 63 of 116 patients (54%). In 20 patients (17%), acute shunt occlusions developed less than 30 days after TIPS creation; in 24 patients (21%), tract abnormalities were detected after 30 days; and in 19 patients (16%), hepatic vein stenoses were detected after 30 days. Abnormalities of the parenchymal tract were more often correlated with recurrent variceal bleeding or ascites than were hepatic vein stenoses (odds ratio, 3.6; P = .02). Ten of 14 patients (71%) with detected biliary fistulas to their TIPS had symptoms, and all patients with biliary fistulas had tract abnormalities. CONCLUSION: Tract stenoses and occlusions were the major cause of symptomatic shunt failure after TIPS creation. Substantial bile duct transections are often associated with tract abnormalities and recurrent symptoms. Although common, hepatic vein stenoses were rarely associated with recurrent symptoms in our patient population.


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
N. Hidajat, A. Stupavsky, J. Gellermann, M. Kreuschner, H. Stahl, P. Wust, R. Felix, and R.-J. Schroeder
Intraluminal Brachytherapy of De Novo TIPS: A Prospective Randomized Double-Blind Study.
Am. J. Roentgenol., April 1, 2006; 186(4): 1133 - 1137.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. Vignali, I. Bargellini, M. Grosso, G. Passalacqua, F. Maglione, F. Pedrazzini, P. Filauri, R. Niola, R. Cioni, and P. Petruzzi
TIPS with Expanded Polytetrafluoroethylene-Covered Stent: Results of an Italian Multicenter Study
Am. J. Roentgenol., August 1, 2005; 185(2): 472 - 480.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. Rossi, F. M. Salvatori, F. Fanelli, M. Bezzi, M. Rossi, G. Marcelli, D. Pepino, O. Riggio, and R. Passariello
Polytetrafluoroethylene-covered Nitinol Stent-Graft for Transjugular Intrahepatic Portosystemic Shunt Creation: 3-year Experience
Radiology, June 1, 2004; 231(3): 820 - 830.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. C. J. ter Borg, M. Hollemans, H. R. van Buuren, F. P. Vleggaar, M. Groeneweg, W. C. J. Hop, and J. S. Lameris
Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3-9 Years
Radiology, May 1, 2004; 231(2): 537 - 545.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. J. Wallace, K. Ahrar, L. C. Stephens, and K. C. Wright
Transvenous Extrahepatic Portacaval Shunt: Feasibility Study in a Swine Model
Radiology, July 1, 2003; 228(1): 119 - 125.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Z. W. Zhuang, G. J. Teng, R. F. Jeffery, J. M. Gemery, B. J. d'Othee, and M. A. Bettmann
Long-Term Results and Quality of Life in Patients Treated with Transjugular Intrahepatic Portosystemic Shunts
Am. J. Roentgenol., December 1, 2002; 179(6): 1597 - 1603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. Otal, T. Smayra, C. Bureau, J. M. Peron, V. Chabbert, P. Chemla, F. Joffre, J. P. Vinel, and H. Rousseau
Preliminary Results of a New Expanded-Polytetrafluoroethylene--Covered Stent-Graft for Transjugular Intrahepatic Portosystemic Shunt Procedures
Am. J. Roentgenol., January 1, 2002; 178(1): 141 - 147.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Z. J. Haskal
Improved Patency of Transjugular Intrahepatic Portosystemic Shunts in Humans: Creation and Revision with PTFE Stent-Grafts
Radiology, December 1, 1999; 213(3): 759 - 766.
[Abstract] [Full Text]


Home page
RadiologyHome page
M. Cejna, M. Peck-Radosavljevic, S. A. Thurnher, K. Hittmair, M. Schoder, and J. Lammer
Creation of Transjugular Intrahepatic Portosystemic Shunts with Stent-Grafts: Initial Experiences with a Polytetrafluoroethylene-covered Nitinol Endoprosthesis
Radiology, November 1, 2001; 221(2): 437 - 446.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1998 by the Radiological Society of North America.